FR2940123B1 - ASSOCIATION OF COMPOUNDS FOR THE TREATMENT OR PREVENTION OF HEAT BURSTS AND SUES BEEN GENERATED BY THE MENOPAUSE - Google Patents

ASSOCIATION OF COMPOUNDS FOR THE TREATMENT OR PREVENTION OF HEAT BURSTS AND SUES BEEN GENERATED BY THE MENOPAUSE

Info

Publication number
FR2940123B1
FR2940123B1 FR0807353A FR0807353A FR2940123B1 FR 2940123 B1 FR2940123 B1 FR 2940123B1 FR 0807353 A FR0807353 A FR 0807353A FR 0807353 A FR0807353 A FR 0807353A FR 2940123 B1 FR2940123 B1 FR 2940123B1
Authority
FR
France
Prior art keywords
sues
menopause
association
prevention
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0807353A
Other languages
French (fr)
Other versions
FR2940123A1 (en
Inventor
Henni Amine Achite
Jean Yves Roubertou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GRANIONS LAB DES
Original Assignee
GRANIONS LAB DES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GRANIONS LAB DES filed Critical GRANIONS LAB DES
Priority to FR0807353A priority Critical patent/FR2940123B1/en
Publication of FR2940123A1 publication Critical patent/FR2940123A1/en
Application granted granted Critical
Publication of FR2940123B1 publication Critical patent/FR2940123B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
FR0807353A 2008-12-22 2008-12-22 ASSOCIATION OF COMPOUNDS FOR THE TREATMENT OR PREVENTION OF HEAT BURSTS AND SUES BEEN GENERATED BY THE MENOPAUSE Active FR2940123B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0807353A FR2940123B1 (en) 2008-12-22 2008-12-22 ASSOCIATION OF COMPOUNDS FOR THE TREATMENT OR PREVENTION OF HEAT BURSTS AND SUES BEEN GENERATED BY THE MENOPAUSE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0807353A FR2940123B1 (en) 2008-12-22 2008-12-22 ASSOCIATION OF COMPOUNDS FOR THE TREATMENT OR PREVENTION OF HEAT BURSTS AND SUES BEEN GENERATED BY THE MENOPAUSE

Publications (2)

Publication Number Publication Date
FR2940123A1 FR2940123A1 (en) 2010-06-25
FR2940123B1 true FR2940123B1 (en) 2011-04-22

Family

ID=40921981

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0807353A Active FR2940123B1 (en) 2008-12-22 2008-12-22 ASSOCIATION OF COMPOUNDS FOR THE TREATMENT OR PREVENTION OF HEAT BURSTS AND SUES BEEN GENERATED BY THE MENOPAUSE

Country Status (1)

Country Link
FR (1) FR2940123B1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6209700A (en) * 1999-07-13 2001-01-30 Cedars-Sinai Medical Center Method and compositions for inhibiting biosynthesis or bioactivity of endogenoussteroid sex hormones in humans
FR2823672B1 (en) * 2001-04-23 2004-03-12 Berkem Sa HOP EXTRACTS AND THEIR USE IN THE PREPARATION OF A MEDICINAL PRODUCT HAVING ESTROGENIC PROPERTIES
US20080057140A1 (en) * 2005-01-10 2008-03-06 Mikko Unkila Use of a Lignan for the Manufacture of a Composition for Preventing or Alleviating of Symptoms Relating to Estrogen Deficiency
FR2893848B1 (en) * 2005-11-28 2011-11-11 Physcience PHYTOHORMONAL COMPOSITION AND ITS USE AS A HORMONAL SUBSTITUTE
FR2898059B1 (en) * 2006-03-06 2010-10-08 Physcience PHYTOHORMONAL COMPOSITION CONTAINING SAGE

Also Published As

Publication number Publication date
FR2940123A1 (en) 2010-06-25

Similar Documents

Publication Publication Date Title
IL253038A0 (en) Compositions and methods for the treatment of the prevention oral infections by e. coli
WO2010088518A3 (en) Heterocyclic modulators of gpr119 for treatment of disease
EP2118074A4 (en) Compounds for the prevention and treatment of cardiovascular diseases
SMT201600055B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF GLAUCOMA
FR2957246B1 (en) ORTHOPEDIC DEVICE FOR THE TREATMENT OF HALLUX VALGUS BY REACTATION OF HALLUX VALGUS BY MECHANICAL EFFECT
AP2010005480A0 (en) Small molecule inhibitors for the treatment or prevention of denque virus infection.
GB2480772B (en) Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus
IL217768A (en) Laquinimod for the treatment of crohn's disease
HK1217100A1 (en) Compounds and compositions for the detection and treatment of alzheimers disease and related disorders
EP2119443A4 (en) Composition for prevention or treatment of disease associated with thrombus or embolus
WO2009117421A3 (en) Heterocyclic modulators of gpr119 for treatment of disease
HK1146084A1 (en) Methods and compositions for prevention or treatment of rsv infection
IL186749A0 (en) Dihydrothienopyrimidines for the treatment of inflammatory diseases
ZA200806074B (en) Compounds for the treatment of inflammatory disorders
EP2519248A4 (en) Methods for the prevention or treatment of vessel occlusion injury
FR23C1002I2 (en) 2,4,6-TRIFLUORO-N-Ý6-(L-METHYL-PIPERIDIN-4- CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE FOR THE TREATMENT OF MIGRAINE BY ORAL OR INTRAVENOUS USE
FR2934501B1 (en) FIRE RISK PREVENTION SYSTEM
HK1221905A1 (en) Use of phy906 as treatment for inflammatory bowel disease and/or irritable bowel syndrome phy906 /
EP2258374A4 (en) Use of maslinic acid for the treatment of diseases and the symptoms thereof by means of cox-2 inhibition
FR2917947B1 (en) PHYTOSANITARY COMPOSITION FOR THE PREVENTIVE AND CURATIVE TREATMENT OF MILDIOU
EP2099488A4 (en) Tslp vaccine for the treatment of th2 mediated inflammatory conditions
BRPI1008259A2 (en) composition for the prevention or treatment of irritable bowel syndrome
GB0917745D0 (en) Compositions for the prevention or treatment of migraine
EP2350283A4 (en) Compounds and methods for the treatment of inflammatory diseases of the cns
EP2249843A4 (en) Use of immunogenic compositions for the treatment or prevention of pathogen infections

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16